1. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
2. What action should the Authority take in response to objections raised by the Auditor-General?
3. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
4. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
5. What is the primary purpose of the Committee of Experts on Drug Research?
6. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
7. What is the duration of a license to export drugs?
8. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
9. In what circumstances shall a drug not be deemed misbranded or adulterated?
10. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
11. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
12. For drugs other than those falling under specific categories, whose approval is required for the specifications?
13. What is the short title of the rules that govern the Drugs Appellate Board?
14. What are "Medicated Cosmetics" under Schedule-I?
15. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
16. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
17. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
18. In which circumstances may the Registration Board register a drug on its own motion?
19. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
20. Within what time frame should the Authority submit its annual report to the Federal Government?
21. Who is responsible for maintaining records of quarterly production and disposal of a drug?
22. What is the Appellate Board's authority to call for the record of a case for review?
23. What is the maximum allowable retailer's discount for drugs?
24. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
25. What are the types of licences to manufacture drugs under Drugs Licensing, Registering & Advertising rules 1976?
26. Which of the following criteria should promotional claims about drugs adhere to?
27. Which type of research involves intervention, treatment, or medication programs using human subjects?
28. Which of the following statements about advertisement material is NOT true?
29. What is the purpose of the criteria regarding medical representatives?
30. What substances are NOT included in the definition of "Drug" under Schedule-I?
31. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
32. Which of the following is NOT considered as "Therapeutic goods" under the Act?
33. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
34. In which situations may the Registration Board provisionally register a drug for a period of two years?
35. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
36. What is the purpose of the Committee on Drugs Evaluation?
37. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
38. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
39. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
40. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
41. The Central Research Fund fee collected by the Authority will be utilized for:
42. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
43. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
44. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
45. What labeling requirements apply to drugs manufactured for experimental purposes?
46. Who qualifies as a Federal Inspector according to these rules?
47. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
48. What condition must be met for an application for renewal of a licence to be entertained?
49. What is the purpose of Schedule-III of the DRAP Act?
50. What is the fee for the renewal of registration of a new drug?
51. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
52. What is the role of the Quality Control Department in the manufacturing process?
53. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
54. What is the purpose of Form 6?
55. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
56. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
57. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
58. Who is responsible for carrying out the audit of the Authority's accounts?
59. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
60. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
61. Within what time frame should the Authority submit its annual report to the Federal Government?
62. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
63. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
64. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
65. What is the duration of a license to import drugs, unless suspended or canceled?
66. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
67. What is the purpose of the Drugs (Research) Rules, 1978?
68. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
69. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
70. Which power of the Inspector requires specific authorization by the Government?
71. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
72. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
73. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
74. Who is considered an "investigator" under the Drugs (Research) Rules?
75. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
76. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
77. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
78. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
79. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
80. Which of the following offenses punishable under Schedule-III is non-cognizable?
81. The Drugs Act, 1976 extends to which of the following areas?
82. How many members does the Policy Board consist of?
83. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
84. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
85. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
86. The Authority shall levy and collect fees for its functions at rates determined by:
87. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
88. Which of the following offenses punishable under Schedule-III is non-cognizable?
89. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
90. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
91. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
92. What are "Medical Devices" under Schedule-I?
93. What is the purpose of Schedule-III of the DRAP Act?
94. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
95. What is the tenure of the CEO's appointment, and how many times can it be extended?
96. What are "Medicated Cosmetics" under Schedule-I?
97. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
98. What type of containers are ophthalmic solutions and suspensions required to be contained in?
99. Under what conditions are drug advertisements to the general public generally permitted?
100. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
